Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

Nvidia Corporation's integration of hardware and software in AI and serverless computing makes it a strong buy. Click for the ...

The bank plans to potentially reintroduce a stock buyback program in 2025, while continuing to prioritize addressing credit challenges. The timeline to resolve legacy credit issues has been extended ...

AGNC Investment Corp. preferreds offer high yields, zero credit risk, and strong capital profile. Click for our updated look ...

Analyst evaluates Nutanix's growth prospects, cost pressures, and stock valuation in light of earnings growth and industry ...

Palantir Technologies Inc. posts strong growth but stock compensation impacts earnings. Click for this PLTR earnings update.

Financial writer reviews Flexsteel Industries, Inc.'s Q2 results showing revenue and income growth, but warns of high stock ...

Suntory is poised for EBIT growth in 2025 due to price hikes and cost optimization, making it potentially an undervalued ...

American Axle & Manufacturing is merging with UK-based Dowlais Group to tackle industry transitions and diversify, growing to ...

Q4 2024 financial results surpassed estimates, but the company did not release an outlook due to its proposed merger with ...

Financial writer discusses American Woodmark's declining stock, internal growth initiatives, and risks associated with ...

Discover how reliable insurers and Buffett-style stocks can help protect against market shocks and offer stable returns with ...